Toll-Like Receptor 4 Deficiency Ameliorates Propofol-Induced Impairments of Cognitive Function and Synaptic

Qiao-Ding Dai1, Kang-Song Wu2, Li-Ping Xu1

  • 1Department of Rheumatology and Immunology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, China.

Molecular Neurobiology
|August 29, 2023
PubMed

Insights

Repeated propofol exposure in young mice impairs spatial memory. This cognitive deficit is linked to reduced hippocampal synaptic function via Toll-like receptor 4 (TLR4) activation.

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Developmental Biology

Background:

  • Propofol is a widely used anesthetic in pediatric patients.
  • Developing brain exposure to propofol may cause long-term behavioral issues.
  • Mechanisms of propofol-induced cognitive impairment in the developing brain are not fully understood.

Purpose of the Study:

  • To investigate the effects of repeated propofol exposure on cognitive function in young mice.
  • To elucidate the underlying synaptic and molecular mechanisms of propofol-induced cognitive deficits.

Main Methods:

  • Repeated propofol administration to mice during the second postnatal week.
  • Assessment of spatial learning and memory.
  • Electrophysiological analysis of hippocampal CA1 neurons.
  • Investigation of the Toll-like receptor 4 (TLR4)-myeloid differentiation primary response protein 88 (MyD88)-NF-κB signaling pathway.
  • Evaluation in TLR4-deficient mice.

Main Results:

  • Propofol exposure impaired spatial learning and memory in young mice.
  • Reduced excitatory synaptic function and synaptogenesis were observed in hippocampal CA1 neurons.
  • Propofol activated the TLR4-MyD88-NF-κB signaling pathway.
  • TLR4 deficiency prevented propofol-induced synaptic and cognitive deficits.

Conclusions:

  • Repeated propofol exposure during brain development causes cognitive impairment.
  • Activation of the TLR4-mediated pathway is a key mechanism underlying these deficits.
  • Targeting the TLR4 pathway may offer therapeutic strategies for preventing propofol-induced cognitive dysfunction.